Ambulatory surgery center (ASC) dealmaking is far from frozen. But M&A activity also isn’t exactly on par with the red-hot stretch of the early 2020s, where healthcare transactions came fast and furious, driven by cheap money and aggressive investors. Instead, today’s ASC market is shaped by steady deal flow, healthy interest from private equity and health systems, and buyers that are still eager to deploy capital on selective terms. According to VMG Health’s 2026 Healthcare M&A Report, the median total invested capital-to-EBITDA multiple for ASC transactions ticked up to 7.9 times in 2025, the highest level in at least eight years. Best-in-class ASC assets have commanded double-digit multiples in select cases.
Read the full article: ASC M&A Activity Continues as Health Systems, PE Widen the Dealmaking Field //
Source: https://ascnews.com/2026/05/asc-ma-activity-continues-as-health-systems-pe-widen-the-dealmaking-field/